04/17/2025
3:05 PM | Denali Therapeutics (Filer)
| Form DEF 14A | |
04/17/2025
3:06 PM | Denali Therapeutics (Filer)
| Form DEFA14A | |
04/17/2025
3:07 PM | Denali Therapeutics (Filer)
| Form ARS | |
04/17/2025
2:05 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/02/2025
7:02 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:26 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:11 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
02/27/2025
3:12 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Denali Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2025
1:14 PM | Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
9:52 AM | BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for DNLI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Denali Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/13/2025
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:23 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:24 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:25 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:26 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:01 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:03 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:06 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:08 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:10 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:12 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:14 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
5:56 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:57 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:17 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
3:18 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:44 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:19 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:39 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
10/18/2024
3:19 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
3:37 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:25 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:25 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:15 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:16 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
3:40 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:42 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:27 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
12:18 PM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/15/2024
3:10 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:36 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:37 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
5:52 AM | Denali Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
5:48 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
3:38 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
7:06 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:31 PM | Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:32 PM | Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:33 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:20 PM | Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:27 PM | Denali Therapeutics (Issuer)
Harris Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:28 PM | Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:29 PM | Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:30 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:30 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:01 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
